First in Human Study of TOS-358 in Adults with Soid Tumors
Phase 1
Recruiting
- Conditions
- 9 main solid tumors – colorectal, cervical, endometrial, gastric, urothelial, breast, head and neck, ovarian and non-small cell lung cancers.MedDRA version: 21.1Level: LLTClassification code: 10065147Term: Malignant solid tumor Class: 10029104Therapeutic area: Diseases [C] - Neoplasms [C04]
- Registration Number
- CTIS2023-505346-26-01
- Lead Sponsor
- Totus Medicines Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method